Taixinsheng
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Taixinsheng, covering 2025-04-09 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 2]